Clinical Trial Update: Long-term Study in Chronic Kidney Disease (Extension From Study 14817) [Phase 3]

View source ↗

Summary

This entry notes the completion of a long-term extension of a Phase 3 trial in hyperphosphatemia associated with chronic kidney disease sponsored by Bayer (Stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Hyperphosphatemia

Snippet

Sponsor: Bayer | Conditions: Hyperphosphatemia | Phase 3 | Status: COMPLETED